NQO1-Activatable Circular Antisense Oligonucleotides for Tumor-Cell-Specific Survivin Gene Silencing and Antitumor Therapy.

Fuente: PubMed
Salvato in:
Dettagli Bibliografici
Autori principali: Zhao, Xiaoran, Xu, Jianfei, Liang, Xingxing, Wang, Zhongyu, Zhu, Yuejie, Guo, Dongyang, Wang, Jing, Amu, Gubu, Wang, Qian, Yang, Zhenjun, Tang, Xinjing
Natura: Artículo científico
Lingua:en
Pubblicazione: Journal of medicinal chemistry 2025
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1868266244728160256
author Zhao, Xiaoran
Xu, Jianfei
Liang, Xingxing
Wang, Zhongyu
Zhu, Yuejie
Guo, Dongyang
Wang, Jing
Amu, Gubu
Wang, Qian
Yang, Zhenjun
Tang, Xinjing
author_facet Zhao, Xiaoran
Xu, Jianfei
Liang, Xingxing
Wang, Zhongyu
Zhu, Yuejie
Guo, Dongyang
Wang, Jing
Amu, Gubu
Wang, Qian
Yang, Zhenjun
Tang, Xinjing
Zhao, Xiaoran
Xu, Jianfei
Liang, Xingxing
Wang, Zhongyu
Zhu, Yuejie
Guo, Dongyang
Wang, Jing
Amu, Gubu
Wang, Qian
Yang, Zhenjun
Tang, Xinjing
collection PubMed - marine biology
contents NQO1-Activatable Circular Antisense Oligonucleotides for Tumor-Cell-Specific Survivin Gene Silencing and Antitumor Therapy. Zhao, Xiaoran Xu, Jianfei Liang, Xingxing Wang, Zhongyu Zhu, Yuejie Guo, Dongyang Wang, Jing Amu, Gubu Wang, Qian Yang, Zhenjun Tang, Xinjing Humans NAD(P)H Dehydrogenase (Quinone) Survivin Oligonucleotides, Antisense Gene Silencing Animals Antineoplastic Agents Mice Mice, Nude Cell Line, Tumor Mice, Inbred BALB C Lung Neoplasms NAD(P)H:quinone oxidoreductase-1 (NQO1), a protein highly expressed in tumor cells, serves as an excellent trigger for releasing drugs specifically within tumor cells. In this study, we designed an activatable circular antisense oligonucleotide (cASO) by incorporating a head-to-tail cyclization mediated by an NQO1-responsive trimethyl-locked quinone propionate (Q3PA), coupled with a self-immolative linker. The resulting circular structure prevented the cASO from binding to the target mRNA, thereby avoiding gene silencing. However, upon encountering NQO1, the circular form was converted to a linear form, leading to the silencing of the targeted gene. experiments demonstrated significant tumor-cell-specific activity of the cASO, while studies using an A549-Luc orthotopic lung tumor model revealed a substantial antitumor effect, primarily attributed to the suppression of survivin expression. This NQO1-activatable cASO represents a novel strategy for achieving tumor-cell-specific gene silencing and holds promise for the development of ASO prodrugs with enhanced therapeutic potentials.
format Artículo científico
id pubmed_39921644
institution PubMed
language en
publishDate 2025
publisher Journal of medicinal chemistry
record_format pubmed
spellingShingle NQO1-Activatable Circular Antisense Oligonucleotides for Tumor-Cell-Specific Survivin Gene Silencing and Antitumor Therapy.
Zhao, Xiaoran
Xu, Jianfei
Liang, Xingxing
Wang, Zhongyu
Zhu, Yuejie
Guo, Dongyang
Wang, Jing
Amu, Gubu
Wang, Qian
Yang, Zhenjun
Tang, Xinjing
Humans
NAD(P)H Dehydrogenase (Quinone)
Survivin
Oligonucleotides, Antisense
Gene Silencing
Animals
Antineoplastic Agents
Mice
Mice, Nude
Cell Line, Tumor
Mice, Inbred BALB C
Lung Neoplasms
NQO1-Activatable Circular Antisense Oligonucleotides for Tumor-Cell-Specific Survivin Gene Silencing and Antitumor Therapy. Zhao, Xiaoran Xu, Jianfei Liang, Xingxing Wang, Zhongyu Zhu, Yuejie Guo, Dongyang Wang, Jing Amu, Gubu Wang, Qian Yang, Zhenjun Tang, Xinjing Humans NAD(P)H Dehydrogenase (Quinone) Survivin Oligonucleotides, Antisense Gene Silencing Animals Antineoplastic Agents Mice Mice, Nude Cell Line, Tumor Mice, Inbred BALB C Lung Neoplasms NAD(P)H:quinone oxidoreductase-1 (NQO1), a protein highly expressed in tumor cells, serves as an excellent trigger for releasing drugs specifically within tumor cells. In this study, we designed an activatable circular antisense oligonucleotide (cASO) by incorporating a head-to-tail cyclization mediated by an NQO1-responsive trimethyl-locked quinone propionate (Q3PA), coupled with a self-immolative linker. The resulting circular structure prevented the cASO from binding to the target mRNA, thereby avoiding gene silencing. However, upon encountering NQO1, the circular form was converted to a linear form, leading to the silencing of the targeted gene. experiments demonstrated significant tumor-cell-specific activity of the cASO, while studies using an A549-Luc orthotopic lung tumor model revealed a substantial antitumor effect, primarily attributed to the suppression of survivin expression. This NQO1-activatable cASO represents a novel strategy for achieving tumor-cell-specific gene silencing and holds promise for the development of ASO prodrugs with enhanced therapeutic potentials.
title NQO1-Activatable Circular Antisense Oligonucleotides for Tumor-Cell-Specific Survivin Gene Silencing and Antitumor Therapy.
topic Humans
NAD(P)H Dehydrogenase (Quinone)
Survivin
Oligonucleotides, Antisense
Gene Silencing
Animals
Antineoplastic Agents
Mice
Mice, Nude
Cell Line, Tumor
Mice, Inbred BALB C
Lung Neoplasms
url https://pubmed.ncbi.nlm.nih.gov/39921644/